PDF herunterladen
PSYCH up2date 2019; 13(03): 243-260
DOI: 10.1055/a-0646-9925
Angststörungen, Zwangsstörungen und stressassoziierte Störungen

Die generalisierte Angststörung – ein Update

Jens Plag
,
Jürgen Hoyer
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Update zu:

Generalisierte AngststörungPSYCH up2date 2013; 7(02): 89-104
DOI: 10.1055/s-0032-1332872

Sorgen und Befürchtungen sind das zentrale Element der generalisierten Angststörung (GAS). Die GAS wird in der ICD-11 deutliche konzeptionelle Veränderungen erfahren, die insbesondere der voranschreitenden klinischen und epidemiologischen Forschung Rechnung tragen. Der folgende Artikel stellt ein „Update“ unseres Beitrags aus dem Jahr 2013 dar mit Ergänzungen um aktuelle Befunde und Entwicklungen.
Kernaussagen

  • Patienten mit GAS bedürfen einer spezifischen fachlichen Behandlung.

  • Insbesondere durch eine Erweiterung bzw. Verfeinerung des psychotherapeutischen Repertoires haben sich in den letzten Jahren die Erfolgsaussichten einer Behandlung verbessert.

  • Patientenerwartungen und -präferenzen sind bei der Indikationsentscheidung zu berücksichtigen. Dies beruht auf der Tatsache, dass die vorbestehenden Präferenzen des Patienten für eine pharmakologische versus psychotherapeutische Behandlung die Erfolgsaussichten deutlich beeinflussen (Befunde bei Depression [71]).

Schlüsselwörter

Generalisierte Angststörung - Psychotherapie - Pharmakotherapie - Neurobiologie


Publikationsverlauf

Publikationsdatum:
07. Mai 2019 (online)

Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Beard GM. A Practical Treatise on nervous Exhaustion (Neurasthenia). New York, NY: William Wood; 1880
    Google Scholar
  • 2 Freud S. Über die Berechtigung, von der Neurasthenie einen bestimmten Symptomenkomplex als „Angstneurose“ abzutrennen. Internationale Zeitschrift für Ärztliche Psychoanalyse 1913; 1: 359-362
    Google Scholar
  • 3 Crocq MA. The history of generalized anxiety disorder as a diagnostic category. Dialogues Clin Neurosci 2017; 19: 107-116
    CrossrefPubMedGoogle Scholar
  • 4 World Health Organisation (WHO). The 11th Revision of the International Classification of Diseases (ICD-11) – Generalized Anxiety Disorder. Im Internet: Zugriff am 19. Dezember 2018 unter: https://icd.who.int/dev11/f/en%23/http%253a%252f%252fid.who.int%252ficd%252fentity%252f1712535455
    Google Scholar
  • 5 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders. 5th ed. Washington, DC: APA; 2013
    CrossrefGoogle Scholar
  • 6 Hoyer J, Becker ES, Roth WT. Characteristics of worry in GAD patients, social phobics, and controls. Depress Anxiety 2001; 13: 89-96
    CrossrefPubMedGoogle Scholar
  • 7 Becker E, Margraf J. Generalisierte Angststörung. Ein Therapieprogramm. Weinheim: Beltz; 2007
    Google Scholar
  • 8 Becker ES, Hoyer J. Generalisierte Angststörung. Göttingen: Hogrefe; 2005
    Google Scholar
  • 9 Jacobi F, Höfler M, Siegert J. et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014; 23: 304-319
    CrossrefPubMedGoogle Scholar
  • 10 Altunoz U, Kokurcan A, Kirici S. et al. Clinical characteristics of generalized anxiety disorder: older vs. young adults. Nord J Psychiatry 2018; 72: 97-102
    CrossrefPubMedGoogle Scholar
  • 11 Nilsson J, Sigström R, Östling S. et al. Changes in the expression of worries, anxiety, and generalized anxiety disorder with increasing age: A population study of 70 to 85-year-olds. Int J Geriatr Psychiatry 2018; DOI: 10.1002/gps.5012.
    CrossrefPubMedGoogle Scholar
  • 12 Wittchen HU. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety 2002; 16: 162-171
    CrossrefPubMedGoogle Scholar
  • 13 Friborg O, Martinussen M, Kaiser S. et al. Comorbidity of personality disorders in anxiety disorders: a meta-analysis of 30 years of research. J Affect Disord 2013; 145: 143-155
    CrossrefPubMedGoogle Scholar
  • 14 Goldstein-Piekarski AN, Williams LM, Humphreys K. A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders. Transl Psychiatry 2016; 6: e847
    CrossrefPubMedGoogle Scholar
  • 15 Tully PJ, Cosh SM. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta-analysis. J Health Psychol 2013; 18: 1601-1616
    CrossrefPubMedGoogle Scholar
  • 16 Bandelow B. Generalized Anxiety Disorder and Pain. Mod Trends Pharmacopsychiatry 2015; 30: 153-165
    CrossrefPubMedGoogle Scholar
  • 17 Csupak B, Sommer JL, Jacobsohn E. et al. A population-based examination of the co-occurrence and functional correlates of chronic pain and generalized anxiety disorder. J Anxiety Disord 2018; 56: 74-80
    CrossrefPubMedGoogle Scholar
  • 18 Toghanian S, Dibonaventura M, Järbrink K. et al. Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe. Clinicoecon Outcomes Res 2014; 6: 151-163
    PubMedGoogle Scholar
  • 19 Moon CM, Jeong GW. Alterations in white matter volume and its correlation with clinical characteristics in patients with generalized anxiety disorder. Neuroradiology 2015; 57: 1127-1134
    CrossrefPubMedGoogle Scholar
  • 20 Moon CM, Jeong GW. Abnormalities in gray and white matter volumes associated with explicit memory dysfunction in patients with generalized anxiety disorder. Acta Radiol 2017; 58: 353-361
    CrossrefPubMedGoogle Scholar
  • 21 Kim GW, Yoon W, Jeong GW. Whole-brain volume alteration and its correlation with anxiety severity in patients with obsessive-compulsive disorder and generalized anxiety disorder. Clin Imaging 2018; 50: 164-170
    CrossrefPubMedGoogle Scholar
  • 22 Fonzo GA, Etkin A. Affective neuroimaging in generalized anxiety disorder: an integrated review. Dialogues Clin Neurosci 2017; 19: 169-179
    CrossrefPubMedGoogle Scholar
  • 23 Nitschke JB, Saarinopoulos I, Oathes DJ. et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009; 166: 302-310
    CrossrefPubMedGoogle Scholar
  • 24 Plag J, Ströhle A. Angststörungen: Neurobiologie. In: Gründer G, Benkert O. Hrsg. Handbuch der psychiatrischen Pharmakotherapie. 2. Aufl.. Heidelberg: Springer; 2012
    Google Scholar
  • 25 Blair KS, Geraci M, Smith BW. et al. Reduced dorsal anterior cingulate cortical activity during emotional regulation and top-down attentional control in generalized social phobia, generalized anxiety disorder, and comorbid generalized social phobia/generalized anxiety disorder. Biol Psychiatry 2012; 72: 476-482
    CrossrefPubMedGoogle Scholar
  • 26 Ball TM, Ramsawh HJ, Campbell-Sills L. et al. Prefrontal dysfunction during emotion regulation in generalized anxiety and panic disorders. Psychol Med 2013; 43: 1475-1486
    CrossrefPubMedGoogle Scholar
  • 27 Krain AL, Gotimer K, Hefton S. et al. A functional magnetic resonance imaging investigation of uncertainty in adolescents with anxiety disorders. Biol Psychiatry 2008; 63: 563-568
    CrossrefPubMedGoogle Scholar
  • 28 Hettema JM, Prescott CA, Kendler KS. A population-based twin study of generalized anxiety disorder in men and women. J Nerval Ment Dis 2001; 189: 413-420
    CrossrefPubMedGoogle Scholar
  • 29 Mackintosh MA, Gatz M, Loebach Wetherell J. et al. A twin study of lifetime generalized anxiety disorder (GAD) in older adults: Genetic and environmental influences shared by neuroticism and GAD. Twin Res Human Genetics 2008; 9: 30-37
    CrossrefGoogle Scholar
  • 30 Dellava JE, Kendler KS, Neale MC. Generalized anxiety disorder and anorexia nervosa: evidence of shared genetic variation. Depress Anxiety 2011; 28: 728-733
    CrossrefPubMedGoogle Scholar
  • 31 Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialogues Clin Neurosci 2017; 19: 159-168
    CrossrefPubMedGoogle Scholar
  • 32 Vreeburg SA, Zitman FG, van Pelt J. et al. Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med 2010; 72: 340-347
    CrossrefPubMedGoogle Scholar
  • 33 Plag J, Schumacher S, Schmid U. et al. Baseline and acute changes in the HPA system in patients with anxiety disorders: the current state of research. Neuropsychiatry (London) 2013; 3: 45-62
    CrossrefGoogle Scholar
  • 34 Brosschot JF, Van Dijk E, Thayer JF. Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period. Int J Psychophysiol 2007; 63: 39-47
    CrossrefPubMedGoogle Scholar
  • 35 Chalmers JA, Quintana DS, Abbott MJ. et al. Anxiety Disorders are associated with reduced heart rate variability: a meta-analysis. Front Psychiatry 2014; 5: 80
    CrossrefPubMedGoogle Scholar
  • 36 Borkovec TD, Alcaine OM, Behar E. Avoidance Theory of Worry and generalized Anxiety Disorder. In: Heimberg RG, Turk CL, Mennin DS. eds. Generalized Anxiety Disorder: Advances in Research and Practice. New York: Guilford Press; 2004
    Google Scholar
  • 37 Newman MC, Llera SL. A novel theory of experiential avoidance in generalized anxiety disorder: A review and synthesis of research supporting a contrast avoidance model of worry. Clin Psychol Rev 2011; DOI: 10.1016/j.cpr.2011.01.008.
    CrossrefPubMedGoogle Scholar
  • 38 Bandelow B, Wiltink J, Alpers GW. et al. Deutsche S3-Leitlinie Behandlung von Angststörungen (2014). Im Internet: Zugriff am 19. Dezember 2018 unter: https://www.awmf.org/leitlinien/detail/ll/051-028.html
    Google Scholar
  • 39 Newman M, Zainal H, Hoyer J. Cognitive-behavioral treatment for GAD. In: Gerlach A, Gloster AT. The Wiley Handbook of Generalized Anxiety Disorder. Chichester: Wiley; (in press)
    Google Scholar
  • 40 Dugas MJ, Robichaud M. Cognitive-behavioral Treatment for generalized Anxiety Disorder. New York: Routledge; 2007
    Google Scholar
  • 41 Longmore RJ, Worrell M. Do we need to challenge thoughts in cognitive behavior therapy?. Clin Psychol Rev 2007; 27: 173-187
    CrossrefPubMedGoogle Scholar
  • 42 Foa EB, Kozak M. Emotional processing of fear: Exposure to corrective information. Psychol Bull 1986; 99: 20-35
    CrossrefPubMedGoogle Scholar
  • 43 Wells A. Metakognitive Therapie bei Angststörungen und Depression. Weinheim: Beltz; 2011
    Google Scholar
  • 44 Hoyer J, Beesdo-Baum K. Prolonged imaginal Exposure based on Worry Scenarios. In: Neudeck P, Wittchen HU. eds. Exposure Therapy: Rethinking the Model – Refining the Method. New York: Springer; 2012: 245-260
    Google Scholar
  • 45 Hoyer J, Beesdo K, Becker ES. Patientenratgeber Generalisierte Angststörung. Göttingen: Hogrefe; 2007
    Google Scholar
  • 46 Hoyer J, Gloster AT. Psychotherapy for generalized anxiety disorder: Donʼt worry, it works!. Psychiatr Clin North Am 2009; 32: 629-640
    CrossrefPubMedGoogle Scholar
  • 47 Hunot V, Churchill R, Silva de Lima M. et al. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev 2007; (01) CD001848
    PubMedGoogle Scholar
  • 48 Cuijpers P, Gentili C, Banos RM. et al. Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: A meta-analysis. J Anxiety Disord 2016; 43: 79-89
    CrossrefPubMedGoogle Scholar
  • 49 Van der Heiden C, Muris P, Van der Molen HT. Randomized controlled trial on the effectiveness of metacognitive therapy and tolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther 2012; 50: 100-109
    CrossrefPubMedGoogle Scholar
  • 50 Nordahl HM, Borkovec TD, Hagen R. et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. B J Psych Open 2018; 4: 393-400
    CrossrefPubMedGoogle Scholar
  • 51 Andersson E, Hedman E, Wadström O. et al. Internet-based extinction therapy for worry: a randomized controlled trial. Behav Ther 2017; 48: 391-402
    CrossrefPubMedGoogle Scholar
  • 52 Hayes-Skelton SA, Roemer L, Orsillo SM. A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder. J Consult Clin Psychol 2013; 81: 761-773
    CrossrefPubMedGoogle Scholar
  • 53 Leichsenring F, Salzer S, Jaeger U. et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: A randomized, controlled trial. Am J Psychiatry 2009; 166: 875-881
    CrossrefPubMedGoogle Scholar
  • 54 Leichsenring F, Winkelbach C, Leibing E. Psychoanalytisch-orientierte Fokaltherapie der generalisierten Angststörung. Ein Manual. Psychotherapeut 2005; 50: 258-264
    CrossrefGoogle Scholar
  • 55 Vøllestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther 2011; 49: 281-288
    CrossrefPubMedGoogle Scholar
  • 56 Westra HA, Constantino MJ, Antony MM. Integrating motivational interviewing with cognitive-behavioral therapy for severe generalized anxiety disorder: An allegiance-controlled randomized clinical trial. J Consult Clin Psychol 2016; 84: 768-782
    CrossrefPubMedGoogle Scholar
  • 57 Constantino MJ, Westra HA, Antony MM. et al. Specific and common processes as mediators of the long-term effects of cognitive-behavioral therapy integrated with motivational interviewing for generalized anxiety disorder. Psychother Res 2017; 5: 1-13
    Google Scholar
  • 58 Boettcher J, Aström V, Påhlsson D. et al. Internet-based mindfulness treatment for anxiety disorders: a randomized controlled trial. Behav Ther 2014; 45: 241-253
    CrossrefPubMedGoogle Scholar
  • 59 Dahlin M, Andersson G, Magnusson K. et al. Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: A randomized controlled trial. Behav Res Ther 2016; 77: 86-95
    CrossrefPubMedGoogle Scholar
  • 60 Maneeton N, Maneeton B, Woottiluk P. et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2016; 10: 259-276
    CrossrefPubMedGoogle Scholar
  • 61 Albert U, Carmassi C, Cosci F. et al. Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review. Int Clin Psychopharmacol 2016; 31: 249-258
    CrossrefPubMedGoogle Scholar
  • 62 Plag J, Ströhle A. Angststörungen: Klinische Pharmakotherapie. In: Gründer G, Benkert O. Hrsg. Handbuch der psychiatrischen Pharmakotherapie. 2. Aufl.. Heidelberg: Springer; 2012: 1005-1019
    Google Scholar
  • 63 Álvarez E, Olivares JM, Carrasco JL. et al. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Ann Gen Psychiatry 2015; 14: 2
    CrossrefPubMedGoogle Scholar
  • 64 Crits-Christoph P, Newman MG, Rickels K. et al. Combined medication and cognitive therapy for generalized anxiety disorder. J Anxiety Disord 2011; 25: 1087-1094
    CrossrefPubMedGoogle Scholar
  • 65 Beesdo-Baum K, Jenjahn E, Höfler M. et al. Avoidance, safety behavior, and reassurance seeking in generalized anxiety disorder. Depress Anxiety 2012; 29: 948-957
    CrossrefPubMedGoogle Scholar
  • 66 Kasper S, Möller HJ, Volz HP. et al. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. Int Clin Psychopharmacol 2017; 32: 195-204
    CrossrefPubMedGoogle Scholar
  • 67 Ooi SL, Henderson P, Pak SC. Kava for Generalized Anxiety Disorder: A review of current evidence. J Altern Complement Med 2018; 24: 770-780
    CrossrefPubMedGoogle Scholar
  • 68 Gabriel MG, Curtiss J, Hofmann SG. et al. Kundalini Yoga for Generalized Anxiety Disorder: An exploration of treatment efficacy and possible mechanisms. Int J Yoga Therap 2018; 28: 97-105
    CrossrefPubMedGoogle Scholar
  • 69 Hoyer J, Köllner V. Pflanzliche Mittel bei Angststörungen. Eine wirksame und nebenwirkungsarme Ergänzung zur Psychotherapie?. Psychotherapie im Dialog 2015; 16: 56-59
    Artikel in Thieme ConnectGoogle Scholar
  • 70 Kozel FA. Clinical repetitive transcranial magnetic stimulation for posttraumatic stress disorder, generalized anxiety disorder, and bipolar disorder. Psychiatr Clin North Am 2018; 41: 433-446
    CrossrefPubMedGoogle Scholar
  • 71 Mergl R, Henkel V, Allgaier AK. et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patientsʼ choice arm. Psychother Psychosom 2011; 80: 39-47
    CrossrefPubMedGoogle Scholar